Alexi A Wright1, Laura A Hatfield2, Craig C Earle2, Nancy L Keating2. 1. Alexi A. Wright, Dana-Farber Cancer Institute; Alexi A. Wright, Laura A. Hatfield, and Nancy L. Keating, Harvard Medical School; Nancy L. Keating, Brigham and Women's Hospital, Boston, MA; and Craig C. Earle, Cancer Care Ontario and Ontario Institute for Cancer Research, Toronto, Ontario, Canada. alexi_wright@dfci.harvard.edu. 2. Alexi A. Wright, Dana-Farber Cancer Institute; Alexi A. Wright, Laura A. Hatfield, and Nancy L. Keating, Harvard Medical School; Nancy L. Keating, Brigham and Women's Hospital, Boston, MA; and Craig C. Earle, Cancer Care Ontario and Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Abstract
PURPOSE: To date, few studies have examined end-of-life care for patients with ovarian cancer. One study documented increased hospice use among older patients with ovarian cancer from 2000 to 2005. We sought to determine whether increased hospice use was associated with less-intensive end-of-life medical care. PATIENTS AND METHODS: We identified 6,956 individuals age ≥ 66 years living in SEER areas who were enrolled in fee-for-service Medicare, diagnosed with epithelial ovarian cancer between 1997 and 2007, and died as a result of ovarian cancer by December 2007. We examined changes in medical care during patients' last month of life over time. RESULTS: Between 1997 and 2007, hospice use increased significantly, and terminal hospitalizations decreased (both P < .001). However, during this time, we also observed statistically significant increases in intensive care unit admissions, hospitalizations, repeated emergency department visits, and health care transitions (all P ≤ .01). In addition, the proportion of patients referred to hospice from inpatient settings rose over time (P = .001). Inpatients referred to hospice were more likely to enroll in hospice within 3 days of death than outpatients (adjusted odds ratio, 1.36; 95% CI, 1.12 to 1.66). CONCLUSION: Older women with ovarian cancer were more likely to receive hospice services near death and less likely to die in a hospital in 2007 compared with earlier years. Despite this, use of hospital-based services increased over time, and patients underwent more transitions among health care settings near death, suggesting that the increasing use of hospice did not offset intensive end-of-life care.
PURPOSE: To date, few studies have examined end-of-life care for patients with ovarian cancer. One study documented increased hospice use among older patients with ovarian cancer from 2000 to 2005. We sought to determine whether increased hospice use was associated with less-intensive end-of-life medical care. PATIENTS AND METHODS: We identified 6,956 individuals age ≥ 66 years living in SEER areas who were enrolled in fee-for-service Medicare, diagnosed with epithelial ovarian cancer between 1997 and 2007, and died as a result of ovarian cancer by December 2007. We examined changes in medical care during patients' last month of life over time. RESULTS: Between 1997 and 2007, hospice use increased significantly, and terminal hospitalizations decreased (both P < .001). However, during this time, we also observed statistically significant increases in intensive care unit admissions, hospitalizations, repeated emergency department visits, and health care transitions (all P ≤ .01). In addition, the proportion of patients referred to hospice from inpatient settings rose over time (P = .001). Inpatients referred to hospice were more likely to enroll in hospice within 3 days of death than outpatients (adjusted odds ratio, 1.36; 95% CI, 1.12 to 1.66). CONCLUSION: Older women with ovarian cancer were more likely to receive hospice services near death and less likely to die in a hospital in 2007 compared with earlier years. Despite this, use of hospital-based services increased over time, and patients underwent more transitions among health care settings near death, suggesting that the increasing use of hospice did not offset intensive end-of-life care.
Authors: Melissa M Thrall; Heidi J Gray; Rebecca Gaston Symons; Noel S Weiss; David R Flum; Barbara A Goff Journal: Gynecol Oncol Date: 2011-04-15 Impact factor: 5.482
Authors: Alexi A Wright; Nancy L Keating; Tracy A Balboni; Ursula A Matulonis; Susan D Block; Holly G Prigerson Journal: J Clin Oncol Date: 2010-09-13 Impact factor: 44.544
Authors: Micael Lopez-Acevedo; Laura J Havrilesky; Gloria Broadwater; Arif H Kamal; Amy P Abernethy; Andrew Berchuck; Angeles Alvarez Secord; James A Tulsky; Fidel Valea; Paula S Lee Journal: Gynecol Oncol Date: 2013-04-13 Impact factor: 5.482
Authors: Amy S Kelley; Partha Deb; Qingling Du; Melissa D Aldridge Carlson; R Sean Morrison Journal: Health Aff (Millwood) Date: 2013-03 Impact factor: 6.301
Authors: Baohui Zhang; Alexi A Wright; Haiden A Huskamp; Matthew E Nilsson; Matthew L Maciejewski; Craig C Earle; Susan D Block; Paul K Maciejewski; Holly G Prigerson Journal: Arch Intern Med Date: 2009-03-09
Authors: Craig C Earle; Bridget A Neville; Mary Beth Landrum; John Z Ayanian; Susan D Block; Jane C Weeks Journal: J Clin Oncol Date: 2004-01-15 Impact factor: 44.544
Authors: Tarek Assi; Elie El Rassy; Tony Ibrahim; Tania Moussa; Aline Tohme; Fadi El Karak; Fadi Farhat; Salma Faddoul; Marwan Ghosn; Joseph Kattan Journal: Support Care Cancer Date: 2016-10-13 Impact factor: 3.603
Authors: William F Pirl; Joseph A Greer; Kelly Irwin; Inga T Lennes; Vicki A Jackson; Elyse R Park; Daisuke Fujisawa; Alexi A Wright; Jennifer S Temel Journal: J Oncol Pract Date: 2015-03-31 Impact factor: 3.840
Authors: Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Tal Gross; Grace C Hillyer; Dawn L Hershman Journal: Breast Cancer Res Treat Date: 2017-07-27 Impact factor: 4.872
Authors: Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum Journal: Health Serv Res Date: 2018-10-14 Impact factor: 3.402
Authors: Shi-Yi Wang; Jane Hall; Craig E Pollack; Kerin Adelson; Elizabeth H Bradley; Jessica B Long; Cary P Gross Journal: J Geriatr Oncol Date: 2016-01-15 Impact factor: 3.599
Authors: Pallavi Kumar; Alexi A Wright; Laura A Hatfield; Jennifer S Temel; Nancy L Keating Journal: J Clin Oncol Date: 2016-12-19 Impact factor: 44.544
Authors: Shi-Yi Wang; Melissa D Aldridge; Cary P Gross; Maureen Canavan; Emily Cherlin; Rosemary Johnson-Hurzeler; Elizabeth Bradley Journal: Med Care Date: 2016-07 Impact factor: 2.983